IP Library Granted Patent US 9,012,641
Granted Patent B2
US 9,012,641 · App. 14/337,846 · Granted Apr 21, 2015

Crystalline forms of Prasugrel salts

Inventors: Mihaela Tuksar (Cakovec, HR); Tomislav Biljan (Krizevci, HR); Miroslav Zegarac (Zagreb, HR)
Assignee: Teva Pharmaceuticals Industries Ltd.
C07D495/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,012,641
App. No.
14/337,846
Granted
Apr 21, 2015
Kind
B2
Abstract

Salts of prasugrel were prepared including, for example, crystalline forms of prasugrel hydro bromide. These salts are useful, for example, in medicaments that inhibit the aggregation of platelets.

Claims (7)

1. Anhydrous Prasugrel hydrobromide according to formula I:

2. A pharmaceutical composition comprising anhydrous Prasugrel hydrobromide according to Formula I

and at least one pharmaceutically acceptable excipient.

3. A method of producing a pharmaceutical composition comprising combining anhydrous Prasugrel hydrobromide according to Formula I

and at least one pharmaceutically acceptable excipient.

4. A method for inhibiting aggregation of platelets comprising administering a pharmaceutically effective amount of anhydrous Prasugrel hydrobromide according to Formula I

to a subject in need of such treatment.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2025
From: TEVA PHARMACEUTICAL INDUSTRIES LTD.
To: ASSIA CHEMICAL INDUSTRIES LTD.
Reel/Frame 071073/0319 →
Continuity (6)
Continuation 13639453
Provisional Application 61322165 · Apr 8, 2010
Provisional Application 61326882 · Apr 22, 2010
Provisional Application 61348914 · May 27, 2010
Provisional Application 61355304 · Jun 16, 2010
Related Publication 20140336217A1 · Nov 13, 2014